טוען...
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US
PURPOSE: Bone-modifying agents (BMAs) are recommended for women with bone metastasis from breast cancer to prevent skeletal-related events. We examined the usage patterns and identified the factors associated with the use of BMAs (denosumab and intravenous bisphosphonates) among women in the US. PAT...
שמור ב:
| הוצא לאור ב: | Clin Epidemiol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6162990/ https://ncbi.nlm.nih.gov/pubmed/30288124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S175063 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|